Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:791-796
Published online before print January 22, 2008, doi: 10.1161/HYPERTENSIONAHA.107.099598
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/3/791    most recent
HYPERTENSIONAHA.107.099598v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, R. C.
Right arrow Articles by Gopalakrishnan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, R. C.
Right arrow Articles by Gopalakrishnan, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
Hazardous Substances DB
*L-SERINE
*NITRIC OXIDE
*PHENYLEPHRINE
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Hypertension. 2008;51:791.)
© 2008 American Heart Association, Inc.


Original Articles

Nitric Oxide Synthase Inhibition Promotes Endothelium-Dependent Vasodilatation and the Antihypertensive Effect of L-Serine

Ramesh C. Mishra; Saswati Tripathy; Kaushik M. Desai; Dale Quest; Yanjie Lu; Jawed Akhtar; Venkat Gopalakrishnan

From the Department of Pharmacology (R.C.M., S.T., K.M.D., Y.L., V.G.), Division of Cardiology, Royal University Hospital (J.A.), College of Medicine, and the College of Nursing (D.Q.), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Correspondence to Dr Venkat Gopalakrishnan, professor and head, Department of Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5E5 Canada. E-mail venkat.gopal{at}usask.ca

L-serine is a precursor of central neurotransmitters. Its cardiovascular effects are largely unstudied. We compared the in vitro effects of L-serine and acetylcholine in phenylephrine-constricted third-order branches of mesenteric arterioles in the NO synthase inhibitor NG-nitro L-arginine methyl ester (L-NAME), pretreated hypertensive rats, and a control group of normotensive male Sprague-Dawley rats. The changes in mean arterial pressure and heart rate evoked by acute intravenous infusion of either L-serine (0.1 to 3.0 mmol/kg) or acetylcholine (0.1 to 10.0 nmol/kg) were determined in anesthetized rats. L-serine evoked concentration-dependent (10 to 200 µmol/L) vasodilatation in endothelium-intact but not in endothelium-denuded vessels. It was abolished by the inclusion of a combination of apamin (SKCa channel inhibitor) and TRAM-34 (IKCa channel inhibitor) or ouabain (Na+ pump inhibitor) and Ba2+ (Kir channel inhibitor) or when the vessels were constricted by potassium chloride. The maximal response to L-serine was higher in the L-NAME treatment group (control 20% versus L-NAME 40%) in relation to the maximal response to acetylcholine (control 93% versus L-NAME 79%). L-serine evoked a rapid, reversible, dose-dependent fall in mean arterial pressure without increasing heart rate and was more pronounced in L-NAME–treated rats (maximal response: >60 mm Hg) than in the control rats (maximal response: 25 mm Hg). This was inhibited (P<0.01) by apamin+charybdotoxin pretreatment. The in vitro and in vivo data confirm that L-serine promotes vasodilatation in resistance arterioles and evokes a greater fall in mean arterial pressure in NO synthase–inhibited hypertensive rats via activation of apamin and charybdotoxin/TRAM-34-sensitive KCa channels present on the endothelium.


Key Words: amino acids • blood pressure • endothelium • hypertension • vasodilation


Related Article:

Blood Pressure Reduction, Potassium Channels, and the Endothelium: Insights From L-Serine
Jorge E. Jalil
Hypertension 2008 51: 626-628. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
J. E. Jalil
Blood Pressure Reduction, Potassium Channels, and the Endothelium: Insights From L-Serine
Hypertension, March 1, 2008; 51(3): 626 - 628.
[Full Text] [PDF]